Patient vs. Physician as the target of educational outreach about screening for an inherited susceptibility to colorectal cancer

Genetic Testing

Volumn 6, Issue 4, 2002, Pages 281-290

  Loader, Starlene ^a   Shields, Cleveland ^a   Levenkron, Jeffrey C ^a   Fishel, Richard ^b   Rowley, Peter T ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLORECTAL CANCER; DECISION MAKING; DEPRESSION; DOCTOR PATIENT RELATION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; QUESTIONNAIRE; SOCIAL SUPPORT;

COLORECTAL NEOPLASMS; EDUCATION, MEDICAL, CONTINUING; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION; PATIENT EDUCATION;

EID: 12244264171     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/10906570260471813     Document Type: Article

References (38)

1. Aaltonen, L.A. (2000). Hereditary intestinal cancer. Cancer Biol. 10, 289-298.
2. Aaltonen, L.A., Saalovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., Chadwick, R.B., Percesepe, A., Kaariainen, H., Ahtola, H., Eskelinen, M., Harkonen, N., Julkunen, R., Kangas, E., Ojala, S., Tulikoura, J., Valkamo, E., Jarvinen, H., Mecklin, J.-P., and De La Chapelle, A. (1998). Incidence of hereditary nonpolyposis colorectal cancer and molecular screening for the disease. N. Engl. J. Med. 1338, 1481-1487.
3. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L.A., De La Chapelle, A., Peltomaki, P., Mecklin, J.-P., and Jarvinen, H.J. (1999). Cancer risk in mutation carriers of DNA-mismatch -repair genes. Int. J. Cancer 81, 214-218.
4. Aktan-Collan, K., Mecklin, J.-P., Jarvinen, H., Nystrom-Laihti, M., Peltomaki, P., Soderling, I., Uutela, A., De La Chapelle, A., and Kaariainen, H. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int. J. Cancer 89, 44-50.
5. Beck, A.T. (1967). Depression: Clinical, Experimental and Theoretical Aspects. New York: (Harper & Row, New York).
6. Burke, W., Petersen, G., Lynch, P., Botkin, J., Daly, M., Garber, J., Kahn, M.J., McTiernan, A., Offit, K., Thomson, E., and Varricchio, C. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. J. Am. Med. Assn. 277, 915-919.
7. Codori, A.M., Petersen, G.M., Miglioretti, D.L., Larkin, E.K., Bushey, M.T., Young, C., Brensinger, J.D., Johnson, K., Bacon, J.A., and Booker, S.V. (1999). Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiol. Biomarkers & Prev. 8, 345-351.
8. Cunningham, J.M., Kim, C.-Y., Christensen, E.R., Tester, D.J., Parc, Y., Burgart, L.J., Halling, K.C., McDonnell, S.K., Schaid, D.J., Vockley, C.W., Kubly, V., Nelson, H., Michels, V.V., and Thibodeau, S.N. (2001). The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am. J. Hum. Genet. 69, 780-790.
9. De La Chapelle, A. (2001). Hereditary nonpolyposis colorectal cancer: Natural history, mutation detection, and molecular screening. Presented at the American Society of Human Genetics, San Diego, CA.
10. Esplen, M.J., Madlensky, L., Butler, K., McKinnon, W., Bapat, B., Wong, J., Aronson, M., and Gallinger, S. (2001). Motivations and psychosocial impact of genetic testing for HNPCC. Am. J. Med. Genet. 103, 9-15.
11. Farrington, S., Lin-Goerke, J., Ling, J., Wang, Y., Burczak, J.D., Robbins, D.J., and Dunlop, M.G. (1998). Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am. J. Hum. Genet. 63, 749-759.
12. Fiscella, K., Franks, P., and Shields, C.G. (1997). Perceived family criticism and primary care utilization psychosocial and biomedical pathways. Family Proc. 36, 25-41.
13. Guerrette, S., Wilson, T., Gradia, S., and Fishel, R. (1998). Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6; examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol. Cell Biol. 18, 6616-6623.
14. Hakala, T., Mecklin, J.-P., Forss, M., Jarvinen, H., and Lehtovirta, P. (1991). Endometrial carcinoma in the cancer family syndrome. Cancer 68, 1656-1659.
15. Hays, R.D., Sherbourne, C.D., and Mazel, R.M. (1993). The Rand 36-Item Health Survey 1.0. Health Economics 2, 217-227.
16. Horowitz, M., Wilner, N., and Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. Psychosomat. Med. 41, 209-218.
17. Jarvinen, H.J., Aarnio, M., Mustonen, H., Aktancollan, K., Aaltonen, L.A., Peltomaki, P., De La Chapelle, A., and Mecklin, J.-P. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118, 829-834.
18. Jarvinen, H., Mecklin, J.-P., and Sistonen, P. (1995). Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108, 1405-1411.
19. Lerman, C., Marshall, J., Audrain, J., and Gomez-Caminero, A. (1996). Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers. Int. J. Cancer 69, 58-61.
20. Lerman, C., Hughes, C., Trock, B.J., Myers, R.J., Main, D., Bonney, A., Abbaszadegan, M.R., Harty, A.E., Franklin, B.A., Lynch, J.F., and Lynch, H.T. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. J. Am. Med. Assn. 281, 1618-1622.
21. Loader, S., Levenkron, J.C., and Rowley, P.T. (1998). Genetic testing for breast-ovarian cancer susceptibility: A regional trial. Genet. Test. 2, 305-313.
22. Loukola, A., De La Chapelle, A., and Aaltonen, L.A. (1999). Strategies for screening for hereditary non-polyposis colorectal cancer. J. Med. Genet. 36, 819-822.
23. Loukola, A., Eklin, K., Laiho, P., Salovaara, R., Kristo, P., Jarvinen, H., Mecklin, J.P., Launonen, V., and Aaltonen, L.A. (2001). Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res. 61, 4545-4549.
24. Lynch, H.T., Watson, P., Shaw, T.G., Lynch, J.F., Harty, A.E., Franklin, B.A., Kapler, C.R., Tinley, S.T., Liu, B., and Lerman, C. (1999). Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model. Cancer Suppl. 86, 2457-2463.
25. Mecklin, J.P., Jarvinen, H.J., Hakkiluoto, A., Hallikas, H., Hiltunen, K.M., Harkonen, N., Kellokumpu, I., Laitinen, S., Ovaska, J., and Tulikoura, J. (1995). Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis. Colon Rectum 38, 588-593.
26. Miller, S.M. (1987). Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. J. Personality Soc. Psychol. 53, 345-353.
27. Peel, D.J., Ziogas, A., Fox, E.A., Gildea, M., Laham, B., Clements, E., Kolodner, R.D., and Anton-Culver, H. (2000). Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J. Natl. Cancer Inst. 92, 1517-1522.
28. Salovaara, R., Loukola, A., Kristo, P., Kaariainen, H., Ahtola, H., Eskelinen, M., Harkonen, N., Julkunen, R., Kangas, E., Ojala, S., Tulikoura, J., Valkamo, E., Jarvinen, H., Mecklin, J.-P., Aaltonen, L.A., and De La Chapelle, A. (2000). Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J. Clin. Oncol. 18, 2193-2200.
29. Sarason, I.G., Levine, H.M., Basham, R.B., and Sarason, B.R. (1983). Assessing social support: The Social Support Questionnaire. J. Personality Soc. Psychol. 44, 127-139.
30. Shields, C., Franks, P., Harp, J., McDaniel, S., and Campbell, T. (1992). Development of the family emotional involvement and criticism scale (FEICS): A self report scale to measure expressed emotion. J. Marital Family Ther. 18, 395-407.
31. Syngal, S., Weeks, J.C., Schrag, D., Garber, J.E., and Kuntz, K.M. (1998). Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary colorectal cancer mutations. Ann. Int. Med. 129, 787-796.
32. Syngal, S., Fox, E.A., Li, C., Dovidio, M., Eng, C., Kolodner, R.D., and Garber, J.E. (1999). Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. J. Am. Med. Assn. 282, 247-253.
33. Syngal, S., Fox, E.A., Eng, C., Kolodner, R.D., and Garber, J.E. (2000). Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J. Med. Genet. 37, 641-645.
34. Vernon, S.W., Gritz, E.R., Peterson, S.K., Amos, C.I., Perz, C.A., Baile, W.F., and Lynch, P.M. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 16, 73-86.
35. Vernon, S.W., Gritz, E.R., Peterson, S.K., Perz, C.A., Marani, S., Amos, C.I., and Baile, W.F. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol. Biomarkers Prev. 8, 353-360.
36. Weber, T.K., Chin, W.-M., Rodriguez-Bigas, M., Keitz, B., Gilligan, R., O'Malley, L., Urf, E., Diba, N., Pazik, J., and Petrelli, N.J. (1999). Novel hMLH1 and hmsh2 germline mutations in African Americans with colorectal cancer. J. Am. Med. Assn. 281, 2316-2320.
37. Weber, T.K., Yuan, Z., McDermott, D., Petrelli, N., Rodriguez-Bigas, M., Keitz, B., and Ravikumar, T.S. (2001). Functional significance of a novel H718y hMLH1 alteration associated with increased colorectal cancer risk among African-Americans. Am. J. Hum. Genet. 169, 255.
38. Yuan, A., Wong, N., Foulkes, W.D., Albert, L., Manganaro F., Andreutti-Zaugg, C., Iggo, R., Anthony, K., Hsieh, E., Redston, M., Pinsky, L., Trifiro, M., Gordon, P.H., and Lasko, D. (1999). A missense mutation in both Msh2 and Apc in an Ashkenazi Jewish Hnpcc kindred: Implication for clinical screening. J. Med. Genet. 36, 790-793.